Precision Therapies: The Last Mile
Why therapies still take years to reach the patients who need them
-
By
-
Pete Harbin
-
March 12, 2026
-
Clinical Scorecard: Precision Therapies: The Last Mile
At a Glance
| Category | Detail |
|---|
| Condition | Delayed Diagnosis in Rare and Precision Medicine - Impacts on treatment efficacy across various conditions. |
| Key Mechanisms | |
| Target Population | |
| Care Setting | |
Key Highlights
- Diagnosis delays can extend from months to years, impacting treatment efficacy.
- Precision medicine requires timely diagnosis due to smaller patient populations.
- Commercial operations need to adapt to understand patient journeys, not just physician engagement.
- Integrating commercial strategies with clinical insights is crucial for improving diagnosis.
Guideline-Based Recommendations
Diagnosis
Management
- Integrate commercial strategies with clinical insights to improve patient identification.
- Implement specific commercial strategies such as patient education and outreach programs.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Timely diagnosis is critical for effective intervention in precision therapies, leading to better patient outcomes.
Clinical Best Practices
- Foster collaboration between clinical and commercial teams to streamline patient identification.
- Leverage data analytics to map patient journeys and identify bottlenecks.
- Provide ongoing training for primary care physicians on recognizing rare disease symptoms.
References
